Synopsis of the Market: The oncology clinical trials market had a global valuation of USD 8.43 billion in 2022 and is projected to ascend to USD 12.75 billion by 2032, showcasing a compound annual growth rate (CAGR) of 4.7% throughout the forecast period. This market expansion is predominantly fueled by factors such as the escalating incidence of cancer, heightened demand for personalized...